Your browser doesn't support javascript.
loading
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.
Dobi, Anthony; Dubernet, Arthur; Rakoto, Mahary Lalarizo; Seteyen, Anne-Laure Sandenon; Vagner, Damien; Lebeau, Grégorie; Raffray, Loïc; Gasque, Philippe.
Affiliation
  • Dobi A; Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion (Site Félix Guyon), 97400, Saint-Denis, France. anto97440@hotmail.fr.
  • Dubernet A; Centre Hospitalier Universitaire Félix Guyon, Allée Des Topazes CS 11021, 97400, St Denis, La Réunion, France. anto97440@hotmail.fr.
  • Rakoto ML; Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion (Site Félix Guyon), 97400, Saint-Denis, France.
  • Seteyen AS; Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion (Site Félix Guyon), 97400, Saint-Denis, France.
  • Vagner D; Faculté de Médecine, Campus universitaire Ambohitsaina, BP375, Université d'Antananarivo, Antananarivo, Madagascar.
  • Lebeau G; Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion (Site Félix Guyon), 97400, Saint-Denis, France.
  • Raffray L; UMR PIMIT 'Processus Infectieux en Milieu Insulaire Tropical' CNRS 9192, Université de La Réunion, INSERM 1187, IRD 249, 97400, Saint-Denis, France.
  • Gasque P; UMR PIMIT 'Processus Infectieux en Milieu Insulaire Tropical' CNRS 9192, Université de La Réunion, INSERM 1187, IRD 249, 97400, Saint-Denis, France.
Immunol Res ; 70(5): 714-719, 2022 10.
Article in En | MEDLINE | ID: mdl-35679009
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Drug Treatment Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Immunol Res Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Drug Treatment Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Immunol Res Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos